Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of PKC-iota inhibitors for the treatment of breast cancer

Use of PKC-iota inhibitors for the treatment of breast cancer

US Patent 9351981 · Granted May 31, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhancers of neurolysin activity2025
Memory manipulation via modification of protein kinase C zeta activity2022
Method of treating colorectal cancers using a PKC inhibitor2022
Method of treating colorectal cancers using a PKC inhibitor2022
Mirror2022
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Method of treating melanoma using an inhibitor of an atypical protein kinase C2021
Compounds that modulate autoimmunity and methods of using the same2017
Drug targets to overcome de novo drug-resistance in multiple myeloma2017
Therapeutic combinations for use in neoplasia2016